Cellectis S.A. Interest Expense For Financial Liabilities Not At Fair Value Through Profit Or Loss
Cellectis S.A. (CLLS) reported Interest Expense For Financial Liabilities Not At Fair Value Through Profit Or Loss of $5.88 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-20.
Financial Statements › Expense Statement › Interest Expense
ifrs-full:InterestExpenseForFinancialLiabilitiesNotAtFairValueThroughProfitOrLoss · last filed 2026-03-20
- Cellectis S.A. interest expense for financial liabilities not at fair value through profit or loss for the quarter ending 2025-06-30 was $1.50M, a 28.21% increase year-over-year.
- Cellectis S.A. interest expense for financial liabilities not at fair value through profit or loss for the quarter ending 2024-06-30 was $1.17M.
| Period end | Interest Expense For Financial Liabilities Not At Fair Value Through Profit Or Loss 3 month | Interest Expense For Financial Liabilities Not At Fair Value Through Profit Or Loss 6 month | Interest Expense For Financial Liabilities Not At Fair Value Through Profit Or Loss 12 month |
|---|---|---|---|
| 2025-12-31 | $5.88M 20-F · filed 2026-03-20 | ||
| 2025-06-30 | $1.50M 6-K/A · filed 2025-10-14 | $2.80M 6-K/A · filed 2025-10-14 | |
| 2024-12-31 | $4.82M 20-F · filed 2026-03-20 | ||
| 2024-06-30 | $1.17M 6-K/A · filed 2025-10-14 | $2.27M 6-K/A · filed 2025-10-14 | |
| 2023-12-31 | $2.25M 20-F · filed 2026-03-20 |